{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:26:52Z","timestamp":1754162812210,"version":"3.41.2"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>We sought to describe the current use of platelet transfusions, harms associated with platelet transfusion, new methods of platelet processing that attempt to address these harms, and recent platelet transfusion guidance specific to critically ill children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Platelet transfusions have been associated with significant morbidity and mortality. New processing techniques, such as pathogen reduction, have been developed to combat infectious risks but in a recent trial of platelet transfusion thresholds in neonates, transfusing platelets more liberally was associated with increased bleeding and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Recent efforts to develop evidence-based guidelines for platelet transfusion in critically ill children were limited by the lack of evidence. However, given the significant risks, restrictive transfusion thresholds should be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001129","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T04:00:59Z","timestamp":1653883259000},"page":"268-272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric platelet transfusions in critical illness: a narrative review of recent studies"],"prefix":"10.1097","volume":"34","author":[{"given":"Christie","family":"Atchison","sequence":"first","affiliation":[{"name":"Division of Critical Care Medicine, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hera","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne E.","family":"Nellis","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1097\/PCC.0000000000001281","article-title":"A prospective study of the association between clinically significant bleeding in PICU patients and thrombocytopenia or prolonged coagulation times","volume":"18","author":"Moorehead","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcrc.2015.11.010","article-title":"Thrombocytopenia in critically ill patients with severe sepsis\/septic shock: Prognostic value and association with a distinct serum cytokine profile","volume":"32","author":"Tsirigotis","year":"2016","journal-title":"J Crit Care"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ccc.2012.04.007","article-title":"Etiology and significance of thrombocytopenia in critically ill patients","volume":"28","author":"Parker","year":"2012","journal-title":"Crit Care Clin"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/CCM.0000000000003192","article-title":"Platelet transfusion practices in critically ill children","volume":"46","author":"Nellis","year":"2018","journal-title":"Crit Care Med"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1807320","article-title":"Randomized trial of platelet-transfusion thresholds in neonates","volume":"380","author":"Curley","year":"2019","journal-title":"N Engl J Med"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/trf.15855","article-title":"Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States","volume":"60","author":"Goel","year":"2020","journal-title":"Transfusion"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/trf.16443","article-title":"Transfusion practices in a large cohort of hospitalized children","volume":"61","author":"Nellis","year":"2021","journal-title":"Transfusion"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"92.e4","DOI":"10.1016\/j.jpeds.2021.04.002","article-title":"Variation in neonatal transfusion practice","volume":"235","author":"Patel","year":"2021","journal-title":"J Pediatr"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1097\/PCC.0000000000001987","article-title":"International study of the epidemiology of platelet transfusions in critically ill children with an underlying oncologic diagnosis","volume":"20","author":"Nellis","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/trf.16626","article-title":"Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)","volume":"61","author":"Goel","year":"2021","journal-title":"Transfusion"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1655952","article-title":"Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass","volume":"77","author":"Chan","year":"1997","journal-title":"Thromb Haemost"},{"key":"R12-20250730","first-page":"e0172","article-title":"The use of hemostatic blood products in children following cardiopulmonary bypass and associated outcomes","volume":"2","author":"Closson","year":"2020","journal-title":"Crit Care Explor"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/PCC.0000000000002805","article-title":"Transfusion practices in pediatric cardiac surgery requiring cardiopulmonary bypass: a secondary analysis of a clinical database","volume":"22","author":"Hanson","year":"2021","journal-title":"Pediatr Crit Care Med"},{"issue":"(Suppl 1)","key":"R14-20250730","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/SHK.0000000000000078","article-title":"Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards","volume":"41","author":"Pidcoke","year":"2014","journal-title":"Shock"},{"issue":"(n1)","key":"R15-20250730","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1751-2824.2010.01417.x","article-title":"Pathogen inactivation\/reduction of platelet concentrates: turning theory into practice","volume":"5","author":"Gathof","year":"2010","journal-title":"ISBT Sci Ser"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1111\/trf.15538","article-title":"Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonates","volume":"59","author":"Jimenez-Marco","year":"2019","journal-title":"Transfusion"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpeds.2019.01.046","article-title":"Blood utilization and transfusion reactions in pediatric patients transfused with conventional or pathogen reduced platelets","volume":"209","author":"Schulz","year":"2019","journal-title":"J Pediatr"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2018-02-831289","article-title":"Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial","volume":"132","author":"van der Meer","year":"2018","journal-title":"Blood"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/trf.16768","article-title":"Hemostatic efficacy of pathogen-reduced platelets in children undergoing cardiopulmonary bypass","volume":"62","author":"Hsien","year":"2022","journal-title":"Transfusion"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1001\/jama.2019.17478","article-title":"Effect of fresh vs standard-issue red blood cell transfusions on multiple organ dysfunction syndrome in critically ill pediatric patients: a randomized clinical trial","volume":"322","author":"Spinella","year":"2019","journal-title":"JAMA"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/2012.jama.11953","article-title":"Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial","volume":"308","author":"Fergusson","year":"2012","journal-title":"JAMA"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2015.13977","article-title":"Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL Randomized Clinical Trial","volume":"314","author":"Dhabangi","year":"2015","journal-title":"JAMA"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1414219","article-title":"Effects of red-cell storage duration on patients undergoing cardiac surgery","volume":"372","author":"Steiner","year":"2015","journal-title":"N Engl J Med"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0955-3886(00)00134-X","article-title":"Platelet storage lesion and apoptosis: are they related?","volume":"24","author":"Seghatchian","year":"2001","journal-title":"Transfus Apher Sci"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/TA.0000000000002230","article-title":"Regulation of endothelial cell permeability by platelet-derived extracellular vesicles","volume":"86","author":"Miyazawa","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1537-2995.1994.34194098597.x","article-title":"Cytokine generation in stored platelet concentrates","volume":"34","author":"Stack","year":"1994","journal-title":"Transfusion"},{"key":"R28-20250730","first-page":"1766","article-title":"Impact of the duration of platelet storage in critically ill trauma patients","volume":"71","author":"Inaba","year":"2011","journal-title":"J Trauma"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1537-2995.2010.02747.x","article-title":"Storage age of transfused platelets and outcomes after cardiac surgery","volume":"50","author":"Welsby","year":"2010","journal-title":"Transfusion"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1111\/trf.16094","article-title":"Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children","volume":"60","author":"Nellis","year":"2020","journal-title":"Transfusion"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/tmrv.2003.50009","article-title":"Risks associated with transfusion of cellular blood components in Canada","volume":"17","author":"Kleinman","year":"2003","journal-title":"Transfus Med Rev"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"100514","DOI":"10.1016\/j.eclinm.2020.100514","article-title":"Transfusion reactions in pediatric and adolescent young adult haematology oncology and immune effector cell patients","volume":"26","author":"Kohorst","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tracli.2021.08.004","article-title":"Platelet transfusion practice and related transfusion reactions in a large teaching hospital","volume":"29","author":"Liker","year":"2022","journal-title":"Transfus Clin Biol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: definition and review","volume":"33","author":"Toy","year":"2005","journal-title":"Crit Care Med"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/trf.15311","article-title":"A consensus redefinition of transfusion-related acute lung injury","volume":"59","author":"Vlaar","year":"2019","journal-title":"Transfusion"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood-2011-08-370932","article-title":"Transfusion-related acute lung injury: incidence and risk factors","volume":"119","author":"Toy","year":"2012","journal-title":"Blood"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"357.e329","DOI":"10.1016\/j.amjmed.2012.08.019","article-title":"Risk factors and outcomes in transfusion-associated circulatory overload","volume":"126","author":"Murphy","year":"2013","journal-title":"Am J Med"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/trf.13855","article-title":"Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness","volume":"57","author":"Muszynski","year":"2017","journal-title":"Transfusion"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PCC.0000000000002102","article-title":"Platelet transfusion practice and related outcomes in pediatric extracorporeal membrane oxygenation","volume":"21","author":"Cashen","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/PCC.0000000000002851","article-title":"Executive summary of recommendations and expert consensus for plasma and platelet transfusion practice in critically ill children: from the Transfusion and Anemia EXpertise Initiative-Control\/Avoidance of Bleeding (TAXI-CAB)","volume":"23","author":"Nellis","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"(13 Supple 1 1S)","key":"R42-20250730","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/PCC.0000000000002858","article-title":"Plasma and platelet transfusion strategies in critically ill children following noncardiac surgery and critically ill children undergoing invasive procedures outside the operating room: from the Transfusion and Anemia EXpertise Initiative-Control\/Avoidance of Bleeding","volume":"23","author":"Tucci","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"(13 Suppl 1 1S)","key":"R43-20250730","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/PCC.0000000000002857","article-title":"Plasma and platelet transfusion strategies in critically ill children with malignancy, acute liver failure and\/or liver transplantation, or sepsis: from the Transfusion and Anemia EXpertise Initiative-Control\/Avoidance of Bleeding","volume":"23","author":"Lieberman","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"(13 Suppl 1 1S)","key":"R44-20250730","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/PCC.0000000000002856","article-title":"Plasma and platelet transfusions strategies in neonates and children undergoing cardiac surgery with cardiopulmonary bypass or neonates and children supported by extracorporeal membrane oxygenation: from the Transfusion and Anemia EXpertise Initiative-Control\/Avoidance of Bleeding","volume":"23","author":"Cholette","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"(13 Suppl 1 1S)","key":"R45-20250730","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/PCC.0000000000002855","article-title":"Plasma and Platelet Transfusion Strategies in Critically Ill Children Following Severe Trauma, Traumatic Brain Injury, and\/or Intracranial Hemorrhage: From the Transfusion and Anemia EXpertise Initiative-Control\/Avoidance of Bleeding","volume":"23","author":"Russell","year":"2022","journal-title":"Pediatr Crit Care Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:00:58Z","timestamp":1753898458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001129","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"type":"print","value":"1040-8703"},{"type":"electronic","value":"1531-698X"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}